Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Enzinger FM, Weiss SW (2019) Soft Tissue Tumors. Elsevier, USA
2. Xue MF, Chen G, Dai JP et al (2019) Development and validation of a prognostic nomogram for extremity soft tissue leiomyosarcoma. Front Oncol. https://doi.org/10.3389/fonc.2019.00346.Accessed01May2019
3. Guo X, Jo VY, Mills AM et al (2015) Clinically relevant molecular subtypes in leiomyosarcoma. Clin Cancer Res 21:3501–3511. https://doi.org/10.1158/1078-0432.CCR-14-3141
4. Bunz F, Vogelstein B (2018) Cancer Genetics. In: Jameson, Fauci, Kasper ‘et al’(eds) Harrison’s Principles of Internal Medicine, 20th edn. McGraw-Hill Education, USA, pp 452–60
5. Zhang X, Sjöblom T (2021) Targeting loss of heterozygosity: a novel paradigm for cancer therapy. Pharmaceuticals (Basel) 14:57. https://doi.org/10.3390/ph14010057